Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Acute oral toxicity:  LD50 = 936 mg/kg bw (Lynch 1971)
Acute dermal toxicity: LD50 = approx. 5 ml/kg bw (Lynch 1971)

Key value for chemical safety assessment

Additional information

Avaliable toxicity data for isopulegol have been derived with or have been filed under the identity of a respective enantiomer, i.e. (1R,2S,5R)-5-methyl-2-(1-methylethenyl)-cyclohexanol (CAS 89 -79 -2). This enantiomer represents one main component of the registered substance DL-isopulegol and the respective data allow to cover the given toxicological endpoint.

Acute oral toxicity:

In the chosen key study, isopulegol has been administered at doses of 0.313, 0.625, 1.25, 2.5, 5 ml/kg bw (approx. 285, 570, 1140, 2275, 4550 mg/kg bw based on a density of 0.909 g/ml) to Sprague-Dawley rats via gavage (RIFM 1971). The acute oral LD50 of the test substance in rats was found to be 1.030 ml/kg (approx. 936 mg/kg bw).

Acute dermal toxicity:

In the chosen key study, isopulegol has been administered topically (occlusive) for 24 hours at doses of 1.25, 2.5, 5, 10 ml/kg bw (approx. 1140, 2275, 4550, 9090 mg/kg bw based on a density of 0.909 g/ml) to New Zealand White rabbits (RIFM 1971). The skin has been abraded in 2/4 animals per dose group.

The acute dermal LD50 of the test substance in rats has been set at approx. 5 ml/kg bw.

Justification for classification or non-classification

The test substance is to be classified with an R22 or acute oral toxicant (category 4) according to the criteria laid down in 67/548/EEC and regulation (EU) 1272/2008, respectively.

The present data on acute dermal toxicity do not fulfill the criteria laid down in 67/548/EEC and regulation (EU) 1272/2008, and therefore, a non-classification is warranted.